No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
SCPH250117P5000
- 0.00
- 0.000.00%
15min DelayClose Dec 26 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover0.00%IV-46.20%PremiumJan 17, 2025Expiry Date1.58Intrinsic Value100Multiplier21DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
Craig-Hallum Maintains ScPharmaceuticals(SCPH.US) With Buy Rating
Craig-Hallum Issues a Buy Rating on ScPharmaceuticals (SCPH)
Express News | ScPharmaceuticals Inc - Snda Submission for Scp-111 May Be Delayed
Express News | ScPharmaceuticals Inc - Observes Variability in Scp-111 Product Testing
Express News | ScPharmaceuticals: Recently Observed Variability During Shelf-Life Testing in One Lot of Scp-111 Combination Product
Jefferies Maintains ScPharmaceuticals(SCPH.US) With Buy Rating, Cuts Target Price to $13